1. Editorial

   Pages: 1527 - 1527

2. Nuclear medicine and thyroid cancer

   • Suman Jana
   • Hussein M. Abdel-Dayem
   • Iven Young

   Editorial Pages: 1528 - 1532

3. Thallium-201 gated single-photon emission tomography for the assessment of left ventricular ejection fraction and regional wall motion abnormalities in comparison with two-dimensional echocardiography

   • Claudia Bacher-Stier
   • Silvana Müller
   • Georg Riccabona

   Original article Pages: 1533 - 1540

4. Gated single-photon emission tomography imaging protocol to evaluate myocardial stunning after exercise

   • Jun Hashimoto
   • Atsushi Kubo
   • Shigeru Kosuda

   Original article Pages: 1541 - 1546

5. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study

   • Frank Grünwald
   • Thomas Kälicke
   • Hans-Jürgen Biersack

   Original article Pages: 1547 - 1552

6. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions

   • Reinhard Obwegeser
   • Peter Berghammer
   • Helmut Sinzinger

   Original article Pages: 1553 - 1559

7. Evaluation of small-bowel transit for solid and liquid test meal in healthy men and women

   • Roelof Bennink
   • Marc Peeters
   • Luc Mortelmans

   Original article Pages: 1560 - 1566

8. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging

   • Winfried Brenner
   • Hans-Jürgen Klomp
   • Eberhard Henze

   Original article Pages: 1567 - 1571

9. ”Ecstasy”-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology

   • Mathias Schreckenberger
   • Euphrosyne Gouzoulis-Mayfrank
   • Udalrich Buell

   Original article Pages: 1572 - 1579

10. Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography

    • Pedro Almeida
    • Maria João Ribeiro
    • Bernard Bendriem

    Original article Pages: 1580 - 1588

11. Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer

    • Sara Gutiérrez
    • Elisabet Carbonell
    • Ricardo Marcos

    Original article Pages: 1589 - 1596

12. Evaluation of radioiodinated medium chain fatty acids as new diagnostic agents for the determination of hepatic viability

    • Norio Yamamura
    • Yasuhiro Magata
    • Hideo Saji

    Original article Pages: 1597 - 1605

13. Fluorine-18 fluorodeoxyglucose dual-head positron emission tomography in the detection of recurrent differentiated thyroid cancer: preliminary results

    • Marcel P. M. Stokkel
    • John H. M. de Klerk
    • Peter P. van Rijk

    Short communication Pages: 1606 - 1609

14. Quantitation in planar renal scintigraphy: which µ value should be used?

    • Elif Hindié
    • Irène Buvat
    • Pierre Galle

    Short communication Pages: 1610 - 1613

15. Labelling of platelets with indium-111 oxine and technetium-99m hexamethylpropylene amine oxime: suggested methods

    • Margarida Rodrigues
    • Helmut Sinzinger
    • On behalf of the International Society of Radiolabelled Blood Elements (ISORBE)

    Occasional survey Pages: 1614 - 1616

16. Cell Irradiation caused by diagnostic nuclear medicine procedures: dose heterogeneity and biological consequences

    • Isabelle Gardin
    • Marc Faraggi
    • Bernard Bok

    Review article Pages: 1617 - 1626